Here begins the text.



 The Medical Device Single Audit Program (MDSAP) is intended to allow MDSAP Auditing Organizations to conduct a single audit of a medical device manufacturer that will satisfy the relevant requirements of the medical device regulatory authorities participating in the program.

 Japan's Ministry of Health, Labour and Welfare, and the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has been participating to the program since June 2015.

 International partners that are participating in the MDSAP include:

  • Therapeutic Goods Administration of Australia,
  • Brazil's Agência Nacional de Vigilância Sanitária,
  • Health Canada, and
  • U.S. Food and Drug Administration.
  • The World Health Organization (WHO) Prequalification of In Vitro Diagnostics (IVDs) Programme and the European Union (EU) are Official Observers

Trial acceptance of MDSAP Audit Reports

  PMDA will accept MDSAP audit reports as a trial, when it performs QMS compliance inspections  (see details).

Notifications from MDSAP


JCN 3010005007409

Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki,
Chiyoda-ku, Tokyo 100-0013 Japan

  • Contact us
  • Access/Map

Copyright (C) Pharmaceuticals and Medical Devices Agency, All Rights Reserved.